Anti-SS-A antibodies, such as Ro52 and Ro60, are often useful for autoimmune disease diagnosis, and anti-SS-A/Ro52+ also has a prognostic value in SSc-ILD [57]. This evidence concerns the gene TRIM21 and systemic sclerosis.